Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Where this lung cancer information comes from

Men and women discussing lung cancer

On this page are the major sources that we use to put together this section of Cancer Research UK's patient information.

 

About our information

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. 

We try to find patients to review all our sections. If you have had lung cancer, live in the UK, and would like to become a patient reviewer, you can write to us by clicking on contact us.

 

Websites

Cancer Research UK
CancerStats Series

US National Cancer Institute
Information on the treatment of lung cancer
Lung cancer information

 

Books

Principles and practice of oncology (9th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Williams and Wilkins, 2011

 

UK guidelines

The diagnosis and treatment of lung cancer
The National Institute for Health and Care Excellence (NICE), April, 2011
Link to the lung cancer guidelines on the NICE website

Guidelines on the Radical Management of Patients with Lung Cancer
British Thoracic Society and the Society for Cardiothoracic Surgery in Great Britain and Ireland, October 2010 
Link to the guidelines on the British Thoracic Society website

Management of patients with lung cancer
Scottish Intercollegiate Guidelines Network (SIGN), February 2005
Link to the SIGN website

Referral Guidelines for Suspected Cancer
The Institute for Health and Care Excellence (NICE), June, 2005
Link to the referral guidelines on the NICE website

Institute for Health and Care Excellence (NICE) Appraisals

  • Microwave ablation for treating primary lung cancer and metastases in the lung, November 2013
  • Crizotinib for previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene, September 2013
  • Lung cancer (non small cell, EGFR-TK mutation positive) – erlotinib (1st line), June 2012
  • Percutaneous radiofrequency ablation for primary and secondary lung cancers, December 2010
  • Pemetrexed as maintenance treatment for non small cell lung cancer, June 2010
  • Gefitinib (Iressa) for treatment of non small cell lung cancer, July 2010
  • Pemetrexed for the treatment of non small cell lung cancer, September 2009
  • Topotecan for the treatment of small cell lung cancer, November 2009
  • Endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal masses, February 2008
  • Bevacizumab for the treatment of non small cell lung cancer, June 2008
  • Erlotinib for the treatment of non small cell lung cancer, November 2008
  • Pemetrexed for the treatment of non small cell lung cancer, August 2007
  • Photodynamic therapy for localised inoperable endobronchial cancer, November 2005
  • Cryosurgery for malignant endobronchial obstruction, November 2005
  • Photodynamic therapy for advanced bronchial carcinoma, August 2004

Link to the NICE website

Scottish Medicines Consortium (SMC)

  • Pemetrexed for the treatment of non small cell lung cancer, SMC no.531/09, February 2010
  • Pemetrexed as maintenance treatment for non small cell lung cancer, SMC no. 642/10, October 2010
  • Gefitinib (Iressa) for locally advanced or metastatic non small cell lung cancer. SMC 615/10, December 2010
  • Erlotinib (Tarceva) as maintenance treatment for advanced lung cancer. SMC 664/10, December 2010
  • Erlotinib (Tarceva) as first line treatment for advanced non small cell lung cancer, SMC No. (749/11), December 2011
  • Treatment of adults with previously treated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), October 2013

Link to the Scottish Medicines Consortium

 

Articles and reviews

The revised TNM staging system for lung cancer. Rami-Porter et al. Annals of Thoracic and Cardiovascular surgery: vol 15; no 1, 2009.

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group. Jean-Pierre Pignon et al. Journal of Clinical Oncology: vol 26; no 21, July 2008.

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. Goldstraw P et al. Journal of Thoracic Oncology: vol 2, no 8, August 2007.

Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Review. Lester JF, Macbeth F, Toy E, Coles B. 2006.  In: The Cochrane Library, issue 4, 2006. Chichester, UK: John Wiley and Sons, Ltd.

Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Review. The Prophylactic Cranial Irradiation Overview Collaborative Group, 2000. In: The Cochrane Library, issue 2, 2004. Chichester, UK: John Wiley and Sons, Ltd.

 

Specialist reviewers

Mr Eric Lim, Consultant thoracic surgeon
Dr David Gilligan, Consultant oncologist
Dr M Cullen, BSC MD FRCP (Consultant cancer specialist)
Mr Tom Haswell, Glasgow (Patient reviewer)

 

Diagrams

Dee McLean – MeDee Art, Medical Illustration

Rate this page:
Submit rating

 

Rated 3 out of 5 based on 2 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 31 March 2014